Novel heterocyclic oxime derivatives, method for preparing same and pharmaceutical compositions containing same

Details for Australian Patent Application No. 2006208812 (hide)

Owner Les Laboratoires Servier

Inventors Parmenon, Cecile; Dacquet, Catherine; Guillard, Jerome; Caignard, DanielHenri; Viaud-Massuard, Marie-Claude; Ktorza, Alain

Agent Watermark

Pub. Number AU-A-2006208812

PCT Pub. Number WO2006/079719

Priority 0500842 27.01.05 FR

Filing date 26 January 2006

Wipo publication date 3 August 2006

International Classifications

C07D 215/06 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

C07D 215/58 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/079719 Priority application(s): WO2006/079719

11 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006208816-Method for colouring an optical lens comprising a printing primer, and optical coloured lens comprising such a printing primer

2006208811-Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents